Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium
Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
Risk factors for severe and critically ill COVID‐19 patients: a review
Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
Increased antimicrobial resistance during the COVID-19 pandemic
In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
SJ Yong - Infectious diseases, 2021 - Taylor & Francis
Long COVID or post-COVID-19 syndrome first gained widespread recognition among social
support groups and later in scientific and medical communities. This illness is poorly …
support groups and later in scientific and medical communities. This illness is poorly …
Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and …
DMG Halpin, GJ Criner, A Papi, D Singh… - American journal of …, 2021 - atsjournals.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised
many questions about the management of patients with chronic obstructive pulmonary …
many questions about the management of patients with chronic obstructive pulmonary …
Two years into the COVID-19 pandemic: lessons learned
SJR da Silva, JCF do Nascimento… - ACS infectious …, 2022 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
M Manik, RK Singh - Journal of medical virology, 2022 - Wiley Online Library
Balanced immune regulation is crucial for recognizing an invading pathogen, its killing, and
elimination. Toll‐like receptors (TLRs) are the key regulators of the innate immune system. It …
elimination. Toll‐like receptors (TLRs) are the key regulators of the innate immune system. It …
Inflammatory and vascular biomarkers in post‐COVID‐19 syndrome: A systematic review and meta‐analysis of over 20 biomarkers
Severe acute respiratory syndrome coronavirus 2 may inflict a post‐viral condition known as
post‐COVID‐19 syndrome (PCS) or long‐COVID. Studies measuring levels of inflammatory …
post‐COVID‐19 syndrome (PCS) or long‐COVID. Studies measuring levels of inflammatory …
Specialized interferon action in COVID-19
The impacts of interferon (IFN) signaling on COVID-19 pathology are multiple, with both
protective and harmful effects being documented. We report here a multiomics investigation …
protective and harmful effects being documented. We report here a multiomics investigation …
Intensive care management of patients with COVID-19: a practical approach
Abstract SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), is
responsible for the largest pandemic facing humanity since the Spanish flu pandemic in the …
responsible for the largest pandemic facing humanity since the Spanish flu pandemic in the …